About the Company
Harvard Bioscience is a global developer, manufacturer and marketer of life sciences equipment to support research and drug discovery. It is traded on NASDAQ under the stock symbol HBIO. Headquartered in Holliston, Massachusetts, United States, the company has 12 wholly owned subsidiaries. The brands include: Biochrom, BioDrop, BTX, CMA, Data Sciences International (DSI), Harvard Apparatus, HEKA, Hugo Sachs Elektronik, Multi Channel Systems (MCS), Panlab, and Warner Instruments. Its CEO is James Green. The company has approximately 500 employees, with 300 of those in the USA, and five principal manufacturing facilities in New Brighton, Minnesota, Holliston, Massachusetts, Reutlingen, Germany, Barcelona, Spain, and March, Germany.
Exchange
OTC
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Harvard Apparatus Regenerative Technology, Inc.
Harvard Apparatus Regenerative Technology and the McGowan ... - Nasdaq
--Harvard Apparatus Regenerative Technology, Inc., a clinical-stage biotechnology company developing the technology to regenerate organs inside the body to treat severe diseases, today announced ...
Harvard Apparatus Regenerative Technology Reports First Quarter 2024 ...
Harvard Apparatus Regenerative Technology Reports First Quarter 2024 Financial Results and Recent Business Highlights May 13, 2024 4:45 PM ET Harvard Apparatus Regenerative Technology Inc. (HRGN) ...
Harvard Apparatus Regenerative Technology Appoints Mao Zhang to Board ...
Holliston, MA, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN) (“Harvard Apparatus Regenerative Technology” or the “Company”), a clinical ...
Harvard Apparatus Regenerative Technology Announces $5 Million ...
On August 19, 2024, Harvard Apparatus Regenerative Technology, Inc. (the “Company”) entered into a Securities Purchase Agreement (a “Purchase Agreement”) with an investor (the “Investor ...
Harvard Apparatus Regenerative Technology Announces Strategic ...
Holliston, MA, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN) (“Harvard Apparatus Regenerative Technology” or the “Company”), a clinical-stage ...
Harvard Apparatus Regenerative Technology and the McGowan Institute for ...
Holliston, MA, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN) (“Harvard Apparatus Regenerative Technology” or the “Company”), a clinical ...
Harvard Apparatus Regenerative Technology and Renowned ... - Nasdaq
--Harvard Apparatus Regenerative Technology, Inc., a clinical-stage biotechnology company developing the technology to regenerate organs inside the body to treat severe diseases, today announced ...
Harvard Apparatus Regenerative Technology Inc. (HRGN)
Harvard Apparatus Regenerative Technology Announces Strategic Collaboration with Children’s Hospital Capital institute of Pediatrics in Beijing, China to Advance Treatment for Esophageal Atresia ...
Similar Companies
Loading the latest forecasts...